Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo
10.1371/journal.pone.0163209
Saved in:
Main Authors: | Nirvanappa A.C., Mohan C.D., Rangappa S., Ananda H., Sukhorukov A.Y., Shanmugam M.K., Sundaram M.S., Nayaka S.C., Girish K.S., Chinnathambi A., Zayed M.E., Alharbi S.A., Sethi G., Basappa, Rangappa K.S. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Article |
Published: |
Public Library of Science (PLoS)
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/142678 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cells
by: Somu, C., et al.
Published: (2021) -
Correction: Novel Synthetic Oxazines Target NF-kappa B in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo (vol 11, e0163209, 2016)
by: Nirvanappa, Anilkumar C, et al.
Published: (2022) -
The IκB kinase inhibitor ACHP targets the STAT3 signaling pathway in human non-small cell lung carcinoma cells
by: Lee, J.H., et al.
Published: (2021) -
N-substituted pyrido-1,4-Oxazin-3-ones induce apoptosis of hepatocellular carcinoma cells by targeting NF-?B signaling pathway
by: Mohan, C.D, et al.
Published: (2020) -
Novel 1,3,4-oxadiazole induces anticancer activity by targeting NF-κB in hepatocellular carcinoma cells
by: Mohan, C.D, et al.
Published: (2020)